Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
MarketBeatMedtronic’s Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance.
Medtronic’s Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance.